Alx Oncology Holdings (ALXO) Assets Average (2020 - 2026)

Alx Oncology Holdings' Assets Average history runs 7 years deep, the most recent figure standing at $118.7 million for Q1 2026.

• In Q1 2026, Assets Average fell 11.65% year-over-year to $118.7 million; the TTM figure through Mar 2026 stood at $118.7 million (down 11.65% YoY), while the FY2025 annual figure was $103.4 million, down 47.01% from the prior year.
• Assets Average came in at $118.7 million for Q1 2026 at Alx Oncology Holdings, up from $70.9 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $371.9 million in Q1 2022 to a low of $70.9 million in Q4 2025.
• A 5-year average of $218.7 million and a median of $227.6 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average slumped 57.49% in 2025 and fell 11.65% in 2026, its largest moves.
• Alx Oncology Holdings' Assets Average stood at $312.1 million in 2022, then declined by 25.88% to $231.3 million in 2023, then retreated by 27.92% to $166.7 million in 2024, then plunged by 57.49% to $70.9 million in 2025, then soared by 67.44% to $118.7 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $118.7 million, $70.9 million, and $89.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison